Showing results (1171-1180 of 1,842) with videos related to

Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|October 3, 2022
Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United StatesMaria Dall'Era, Kenneth Kalunian, Michael Eaddy, et al.
Journal of Managed Care & Specialty Pharmacy|September 28, 2021
Valuing diversity in value assessment: introducing the PhRMA Foundation Health Disparities Challenge AwardEberechukwu Onukwugha
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverageTerri V Newman, Jingchuan Guo, Inmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspectiveJinan Liu, Carol Hawkes, Lydia Walder, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with Medicaid and commercial coverageAlexa C Klimchak, Shelagh M Szabo, Christina Qian, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Mavacamten for hypertrophic cardiomyopathy: effectiveness and valueMolly Beinfeld, Jason H Wasfy, Surrey Walton, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefitLiam Bendicksen, Aaron S Kesselheim
Journal of Managed Care & Specialty Pharmacy|January 31, 2022
Association between health system specialty pharmacy use and health care costs among national sample of Medicare Advantage beneficiariesSarah S Hellems, Apurv Soni, Dale Fasching, et al.
Journal of Managed Care & Specialty Pharmacy|April 13, 2019
Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy
Pageof 185